To news list
News 11.04.23

Mirpharm has launched a new website dedicated to Indocyanine Green

Mirpharm announces the launch of a new website dedicated to the diagnostic drug Indocyanine Green

Moscow, April 2023


Indocyanine green (Indocyanine green) - an effective and affordable drug for fluorescence imaging during surgery, is characterized by:

●     high safety profile

●     wide dosing range

●     consistently short half-life

●     does not recirculate in a body

●     does not interact with other medications

●     is excreted exclusively through the liver


Fluoro-guided surgery with ICG

Open and endoscopic surgery with fluorescence navigation (FGS, Fluorescence-Guided Surgery):

Dramatically improve visualization of blood flow in the surgical wound

Reduce the risk of surgical complications

Reduce trauma to non-injured tissue

Increase the radicality of the treatment

poses no additional safety risk

well tolerated by patients


Active link to the site - https://icgreen.ru


On the site one can find more information about the drug and where it is produced, in which areas it can be used and even watch some real work cases. In addition, professionals can learn more about fluorescence navigation, suitable equipment producers and the leading institutions where it can be trained.

 

Note:

The press release contains information about prescription medications. Use of this information for preparation of publications must be made in accordance with the legislation of the Russian Federation on advertising (including but not limited to Art. 24 of the Federal Law of 13.03.2006 No. 38-FL "On Advertising"), according to which, in particular, advertising of prescription drugs is allowed only in places of medical or pharmaceutical exhibitions, workshops, conferences and other similar events as well as in specialized print media intended for medical and pharmaceutical specialists. Failure to comply with the above requirements (namely, mentioning the name of the drug, placing an image of the package or its elements in the media other than specialized print publications intended for medical and pharmaceutical specialists) shall entail administrative liability.


Other news

Please read our privacy policy

The present personal data processing policy is drawn up in accordance with the requirements of the Federal Law of July 27, 2006. No. 152-FЗ “On Personal Data” and determines the procedure for processing personal data and measures to ensure the security of personal data of Mir-Pharm LLC (hereinafter referred to as the Operator).

The operator sets as his most important goal and condition for the implementation of his activities the respect for the rights and freedoms of man and citizen in the processing of his personal data, including the protection of the rights to privacy, personal and family confidentiality.

The Operator's policy regarding the processing of personal data (hereinafter - the Policy) applies to all information that the Operator can receive about visitors of the website https://mirpharm.ru.

The user can get any clarification on issues of interest regarding the processing of his personal data by contacting the Operator via e-mail info@mirpharm.ru.

The current version of the Policy is located in free access on the Internet at https://mirpharm.ru/policy.

This document will reflect any changes in the policy of processing personal data by the Operator. The policy is valid indefinitely until it is replaced with a new version.

Read more